Dendreon | search
Click here to view Dendreon news from 60+ newspapers.
Bookmark or Share- Long-suffering Dendreon finds new avatar as contract manufacturer for ...By Kevin Dunleavy Jun 17, 2021 10:35am. bankruptcy Cell & Gene Therapy cell therapy cell therapy manufacturing. Dendreon has invested in a new contract manufacturing and services division to bring ...
- PROVENGE® (sipuleucel-T)PROVENGE is a personalized immunotherapy that activates the immune system to help fight advanced prostate cancer and has been proven to help certain men with metastatic castration-resistant prostate cancer (mCRPC) live longer. Learn more about PROVENGE.
- Dendreon Medical Affairs - Clinical & Safety Information on PROVENGE ...Scheduling, Apheresis, Infusion, Billing, and Reimbursement. This online resource, provided by Dendreon, offers clinical information, including efficacy and adverse events, on PROVENGE immunotherapy for mCRPC to healthcare professionals practicing in the United States.
- Dendreon - Wikipediadendreon .com. Dendreon is a biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells ( autologous, with dendritic cells thought to be the most important) that have been incubated with the Dendreon PAP - GM-CSF fusion ...
- The Dendreon Difference | DendreonTargeting cancer, transforming lives. Dendreon is a commercial-stage biopharmaceutical company and end-to-end provider of manufacturing services for the cell therapy market. Founded on the belief that immunotherapy made from a patient’s own cells will transform disease treatment, Dendreon has worked tirelessly to make the fight against cancer ...
More
